System Labs Tirzepatide Review: Cost, Flat Pricing & Honest Verdict (2026)

System Labs sells exactly one weight-loss product, and it is the one this site is about: a weekly compounded tirzepatide injection, billed at a flat $179/month, month-to-month, at every dose. There is no prepay ladder to decode, no membership fee stacked underneath, and no second molecule competing for the headline. The one number that needs a label is the $99 you will see first — that is a first-month introductory rate, not the ongoing price. This review covers what System Labs is, what it charges, who stands behind the prescribing, and the two things it declines to publish. Every fact here comes from the company's own published program.

What System Labs is

System Labs — legally System Laboratories, Inc. — is an online prescriber running a single GLP-1 program alongside a small longevity catalog (NAD+ injection and nasal spray, sermorelin injection and oral, glutathione, and a MIC+B12 injection sold as an $89 add-on). The GLP-1 flow is deliberately short: a two-minute intake form, a licensed provider who reviews it and follows up by chat rather than by scheduled video visit, then a compounded prescription shipped free in two days, temperature-controlled, with injection supplies included. You can pause or cancel from the dashboard at any time, and there are no per-visit fees and no membership fee.

The product is marketed as "Compounded GLP-1/GIP" rather than by molecule name, which is worth decoding: GLP-1/GIP dual agonist is tirzepatide, and tirzepatide is what the program dispenses. It is a once-weekly subcutaneous injection, clinician-titrated. There is no semaglutide option — if you are specifically after semaglutide, this is not the program.

What System Labs costs in 2026

$179 a month, flat, month-to-month. System Labs states it in its own FAQ, verbatim: "Your subscription is billed at a flat $179/mo with no hidden fees. It includes free 2-day temperature-controlled shipping. Refills are automatic based on your schedule. You can pause or cancel anytime." The buy box sells a "Monthly Supply (All doses)", so titrating from a starting dose up to a therapeutic one does not raise the bill — the thing most compounded programs quietly do to you between month two and month five.

The $99 is a first-month intro, and System Labs labels it as one. The price block shows $179 struck through beside "$99 /first mo.", and the underlying product data marks it as an introductory price rather than a standing one. That is honest presentation on their side, and it is also the number most likely to get quoted out of context elsewhere. Budget on $179; treat the $99 as a one-time $80 saving in month one.

There is no prepay ladder at all. No three-, six- or twelve-month rung, no "from $X/mo" figure that turns out to require a year's payment on day one. In a category where the most visible price on a homepage is very often a twelve-month rate divided by twelve, the absence of a ladder is the feature: the advertised rate and the charged rate are the same number. Compare that with a storefront like Ageless, whose "from $159/mo" hero is a twelve-month rung billed as a single $1,908 payment, or with Oak, which publishes nine different starting figures and attaches a term to none of them.

For the brand benchmark: self-pay Zepbound through LillyDirect runs $299/month at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg and above (28-day supply, prices in effect since December 1, 2025). System Labs's $179 sits below all of those — but it buys a compounded product, not the approved one, which is the trade the next section is about. See our Zepbound cost and savings guide for the full brand picture.

The compounded-vs-brand question

System Labs dispenses compounded tirzepatide, and says so plainly — the lander carries its own bolded FDA disclosure stating the product is not FDA-approved. That distinction is the whole reason the price is what it is:

• •Brand tirzepatide is Eli Lilly's FDA-approved Zepbound (weight management, obstructive sleep apnea) and Mounjaro (type 2 diabetes) — the exact molecule and dose studied in the pivotal trials.
• •Compounded tirzepatide is pharmacy-made, not FDA-approved, and was not the product tested in those trials.

The regulatory ground has narrowed since the FDA declared the tirzepatide shortage resolved in October 2024 and the enforcement discretion permitting routine large-scale compounding ended in early 2025. The full timeline is in our guide to whether compounded tirzepatide is still legal in 2026.

How the care model holds up

What it names. System Labs publishes a medical board with three named physicians: Dr. Marc Gruner, a sports-medicine physician trained at Mayo Clinic; Dr. Jonathan Hinds, board-certified in emergency medicine and trained at Rutgers; and Dr. Gregory Tennant, a fellowship-trained orthopedic trauma surgeon trained at Vanderbilt. Naming clinicians with checkable credentials puts it ahead of most providers here, where the prescriber is an anonymous "licensed provider" and nothing more.

What it does not name. Two gaps, and they are the usual two. First, the compounding pharmacy is not identified — the site says only "a certified U.S. pharmacy." On a product whose quality rests entirely on who mixes it, that is the disclosure that matters most, and it is missing. Second, System Labs does not publish which states it serves. One of its physicians is described as licensed in all 50 states, but that is a fact about a clinician's licensure, not a statement of where the program will actually ship — do not read it as nationwide coverage. You will find out whether you are eligible by starting the intake.

One further caution: the testimonials on the lander are first-name-plus-age and unverifiable, and several of them praise the NAD+ and glutathione products rather than the GLP-1. They are not evidence of anything about tirzepatide outcomes.

As with any GLP-1 service, read the cancellation terms and confirm continuity of supply before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

System Labs is one of the cleaner pricing propositions here: $179/month, flat, at every dose, month-to-month, with the intro rate honestly labeled as an intro rate and no prepay ladder to trip over. If what has put you off this category is arithmetic — headline figures that turn out to be annual prepays, doses that quietly cost more as you titrate, membership fees stacked under the drug price — this is the shape of program that fixes that. Three named physicians is a genuine plus on top.

The reservations are real and specific: the pharmacy is unnamed, the states served are unpublished, and the product is compounded rather than FDA-approved. If knowing which pharmacy compounds your prescription is the thing you will not compromise on, weigh a program that names one instead. Compare the whole field in our best tirzepatide providers ranking, and see cheapest tirzepatide for where $179 actually lands.